Value Delivered
Dr Ian Hudson, speaking at Health Technology Assessment World Europe 2011

Dr Ian Hudson,
Director of Licensing
MHRA

Ian Hudson is a physician, who practiced as a paediatrician with a research interest in neonatal haematology. He then worked in clinical research and development in the pharmaceutical industry for 11 years. Since 2001 he has been the Director of the Licensing Division (Medicines) at the MHRA. He has also been the UK delegate to the CHMP since 2002.


Appearing:
Day One – Wednesday 30 November 2011
12.05pm

Emerging interface between regulators and HTA bodies - how can we harmonise assessment?

• Should there be closer collaboration?
• Collaborative initiatives in Europe
• MHRA/NICE joint scientific advice

Dr Ian Hudson,
Director of Licensing,
MHRA
12.45pm

PANEL SESSION: HTA-regulatory interaction/coordination

Institute for Clinical and Economic Review (ICER) Massachusetts,
General Hospital's Institute for Technology Assessment
Officer, Pharmaceutical Department,
Gemeinsamer Bundesausschuss
Dr Ian Hudson,
Director of Licensing,
MHRA
Chair,
HTAi Policy Forum
Session facilitator sponsor
United BioSource Corporation at Health Technology Assessment World Europe 2011
Presentation Sponsor
PAREXEL International at Health Technology Assessment World Europe 2011
Presentation Sponsor
Bridgehead International Ltd at Health Technology Assessment World Europe 2011
sponsors list

Health Technology Assessment World Europe 2011 is a multi-faceted event

  • A two day conference
  • A showcase 
  • Case studies by industry professionals
  • Speed networking
  • Interactive panel discussions
  • Roundtable brainstorms
  • Live debates

Register now ›
 

You may also like to attend:

  • Pharma Pricing & Market Access Outlook Europe
  • Market Access World USA 

See more ›

We run training courses on:

  • 3 Day MBA in Pharmaceuticals 

See more ›